Avesthagen Limited.
BANGALORE, India, March 23, 2011 - Avesthagen Limited achieves another milestone as it announces the launch
of its commercial Whole Genome Scanning (WGS) service in India.
BANGALORE, India, February 16, 2011 - Avesthagen Limited announced completion of a landmark project
for the development of AvestaDHA(TM) - a vegetarian source of DHA
(docohexanoic acid) omega 3 essential fatty acid based on an innovative
approach using naturally occurring microalgae.
BANGALORE, India, January 3, 2011 - Avesthagen Limited has yet again established its position as a
leader in the successful application of next gen technologies as it announces
the completion of the first Parsi breast cancer whole genome sequence of a
74-year-old Parsi woman with a heritable form of breast cancer.
BANGALORE, India, December 8, 2010 - AVESTHAGEN LIMITED, a leading knowledge based life sciences
company pioneering the convergence between Food, Pharma and Population
Genetics, today announced the completion of manufacturing of the clinical
grade material of its first biosimilar molecule- AVDESP(TM) (biosimilar to
Darbepoetin alfa), which will now be moving into Clinical Trials.
